|
|
|
| Research Grants |
JYOTIKA K. FERNANDES
Medicine. Genetic
Contributors to Diabetes and Dyslipidemia in African Americans, $82,942
from University of Virginia, August through July 2010.
VANESSA K. HINSON
Neurosciences.
Parkinsons Disease Neuroprotection Clinical Trial Center, $18,072 from
National Institute of Neurological Disorders and Stroke, December 2008
through November.
BRENDA J. HOFFMAN
Medicine. A
Phase 3, Randomized, Placebo-Controlled, Blinded, Multi-Center Study of
the Induction and Maintenance of Clinical Response and Remission by
MLN0002 in Patients with Moderate to Severe Crohn’s Disease, $11,550
from Quintiles Pacific Inc., October 2008 through October 2011.
BRUCE W. HOLLIS
CAROL WAGNER (Co-PI)
Pediatrics.
Establishing the Vitamin D Requirements During Lactation, $72,682 from
National Institute of Child Health and Human Development, September
through September 2010.
LORETTA HOOVER
Cell
Biology and Anatomy. Interactions between TGFbeta and Retinoid
Signaling in Cardiac Development, $34,525 from National Heart, Lung and
Blood Institute, September through August 2010.
PAUL F. JACQUES
Health Professions. Project TEACH, $105,667 from Health Resources and Services Administration, July through June 2010.
LANKUPALLE D. JAYANTHI
Neurosciences.
Norepinephrine Transport Regulation by Phosphorylation, $57,290 from
National Institute of General Medical Sciences, September through
August 2011.
JOSEPH M. JENRETTE
Radiation
Oncology. Radiation Therapy Oncology Group (RTOG): Institutional Member
Agreement, $37,500 from Radiation Therapy Oncology Group, January
through December.
MARC A. JUDSON
Medicine.
The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis,
$10,920 from Celgene Corp., May 2007 through April 2010.
MARK S. KINDY
Neurosciences.
Neprilysin and Amyloid-Beta Degradation in Alzheimer’s Disease,
$113,000 from Veterans Affairs Medical Center, April through March 2010.
KEITH L. KIRKWOOD
Craniofacial
Biology. SC COBRE for Oral Health Research: NCRR ARRA Admin Supplement
for Research Workforce Development and Dissemination, $290,019 from
National Center for Research Resources, September through September
2010.
Silencing Post Transcriptional
Signaling Mechanisms in Periodontal Inflammation, $221,250 from
National Institute of Dental and Craniofacial Research, September
through September 2010.
Negative Regulation of Innate
Immune Responses through MAPK Phosphatases, $99,675 from National
Institute of Dental and Craniofacial Research, September through August
2010.
RICHARD L. KLEIN
Medicine.
Interactions of Lipoproteins and Cells in Diabetes Mellitus, $246,500
from Veterans Affairs Medical Center, April through March 2010.
YIANNIS KOUTALOS
Ophthalmology. Transport Processes in Photoreceptors, $32,850 from National Eye Institute, March through February 2010.
JACQUELINE KRAVEKA
Pediatrics.
Role of Bioactive Sphingolipids in Neuroblastoma Progression, $30,000
from National Childhood Cancer Foundation, July through June 2010.
SVEN KROENER
Neurosciences.
Effects of Chronic Alcohol Exposure on Synaptic Plasticity in the
Prefrontal Cortex, $221,250 from National Institute on Alcohol Abuse
and Alcoholism, September through June 2010.
ANDREW KRAFT
Medicine.
MUSC Cancer Center Support Grant: Senior Leadership, $337,915 from
National Cancer Institute, April through March 2010.
MUSC Cancer Center Support Grant: Administration, $151,419 from National Cancer Institute, April through March 2010.
JAMES S. KRAUSE
Health
Sciences and Research. Risk of Adverse Outcomes after SCI: A
Longitudinal Study, $45,764 from National Institute of Neurological
Disorders and Stroke, January through December.
ANDREW B. LAWSON
Medicine.
Development and Evaluation of Spatial Survival Models, $15,483 from
University of South Carolina, September through August 2010.
CHRISTOS LAZARIDIS
Neurosciences.
The ACCELERATE Trial: The Evaluation of Patients with Acute
Hypertension and Intracerebral Hemorrhage with Intravenous Clevidipine
Treatment, $89,000 from The Medicines Co., March through March 2010.
The ACCELERATE Trial:
The Evaluation of Patients with Acute Hypertension and Intracerebral
Hemorrhage with Intravenous Clevidipine Treatment, $10,000 from The
Medicines Co., March through September 2010.
ELIZABETH J. LETOURNEAU
Psychiatry
and Behavioral Sciences. Adapting MST to Address Transmission Risk
Behaviors in HIV+ Young People, $10,181 from National Institute on
Mental Health, February through January.
ANGELLO LIN
Surgery. A
Phase 2, Multi-Center, Open-Label, Active, Comparator-Controlled,
Extension Trial to Evaluate the Long Term Safety and Efficacy of
CP690,550 in Renal Allograft Recipients, $30,407 from Icon Clinical
Research Inc., March through August 2010.
A Randomized, Double-Blind
Study to Assess the Efficacy and Safety of Prophylactic Use of
Maribavir Versus Ganciclovir for the Prevention of Cytomegalovirus
Disease in Recipients of Orthotopic Liver Transplants, $11,500 from
Viropharma Inc., June 2007 through November.
Belatacept Evaluation of
Nephroprotection and Efficacy as First-Line Immunosuppression Trial
(BENEFIT), $30,498 from Bristol Myers Squibb, December 2005 through
December 2010.
GAYENELLE MAGWOOD
Nursing.
Behavioral/Support Intervention for Diet and Exercise among Underserved
Women: Minority Supplement, $105,574 from University of South Carolina,
August through June 2010.
ARCH MAINOUS
Family
Medicine. Reducing Inappropriate Prescribing of Antibiotics by Primary
Care Clinicians, $227,578 from Agency for Healthcare Research and
Quality, August through July 2010.
ANNA-LIISA NIEMINEN
Pharmaceutical
and Biomedical Sciences. Mechanisms of Cell Death after Photodynamic
Therapy, $250,738 from National Cancer Institute, August through July
2010.
Mechanisms of Cell Death after Photodynamic Therapy, $91,564 from National Cancer Institute, August through July 2010.
MICHAEL I. NISHIMURA
Surgery. TCR Affinity and Therapeutic Efficacy of T Cells, $193,653 from National Cancer Institute, August through July 2010.
TCR Affinity and Therapeutic Efficacy of T Cells, $210,247 from National Cancer Institute, September through August 2010.
Friday, Nov. 13, 2009
|
|
|
